CT-P19

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCT-P19
Drug Alias NameCT-P19
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRabies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelltrion Inc
China Registration ClassN/A

Develop Information

Active CompaniesCelltrion Inc
Inactive CompaniesN/A
Active IndicationsRabies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A